Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines.

Farsaci B, Donahue RN, Coplin MA, Grenga I, Lepone LM, Molinolo AA, Hodge JW.

Cancer Immunol Res. 2014 Nov;2(11):1090-102. doi: 10.1158/2326-6066.CIR-14-0076. Epub 2014 Aug 4.

2.

Single agent gefitinib as first line therapy in patients with advanced non-small cell lung cancer: Washington University experience.

Kommareddy A, Coplin MA, Gao F, Behnken D, Romvari E, Read W, Govindan R.

Lung Cancer. 2004 Aug;45(2):221-5.

PMID:
15246194
3.

Lung cancer patient follow-up: motivation of thoracic surgeons.

Virgo KS, Naunheim KS, Coplin MA, Johnson FE.

Chest. 1998 Dec;114(6):1519-34.

PMID:
9872182
4.

How tumor stage affects surgeons' surveillance strategies after lung cancer surgery.

Johnson FE, Naunheim KS, Coplin MA, Virgo KS.

Chest. 1997 Jan;111(1):99-102.

PMID:
8996000
5.

Geographic variation in the conduct of patient surveillance after lung cancer surgery.

Johnson FE, Naunheim KS, Coplin MA, Virgo KS.

J Clin Oncol. 1996 Nov;14(11):2940-9.

PMID:
8918491
6.

How practice patterns in colon cancer patient follow-up are affected by surgeon age.

Johnson FE, Novell LA, Coplin MA, Longo WE, Vernava AM, Wade TP, Virgo KS.

Surg Oncol. 1996 Jun;5(3):127-31.

PMID:
8908718
7.

Geographic variation in patient surveillance after colon cancer surgery.

Johnson FE, McKirgan LW, Coplin MA, Vernava AM, Longo WE, Wade TP, Virgo KS.

J Clin Oncol. 1996 Jan;14(1):183-7.

PMID:
8558196
8.

Clinical surveillance testing after lung cancer operations.

Naunheim KS, Virgo KS, Coplin MA, Johnson FE.

Ann Thorac Surg. 1995 Dec;60(6):1612-6.

PMID:
8787452
9.

Surveillance after curative colon cancer resection: practice patterns of surgical subspecialists.

Virgo KS, Wade TP, Longo WE, Coplin MA, Vernava AM, Johnson FE.

Ann Surg Oncol. 1995 Nov;2(6):472-82.

PMID:
8591076
10.

How tumor stage affects surgeons' surveillance strategies after colon cancer surgery.

Johnson FE, Longo WE, Vernava AM, Wade TP, Coplin MA, Virgo KS.

Cancer. 1995 Oct 15;76(8):1325-9.

PMID:
8620404
11.

Rare anal canal cancers in the U.S. veteran: patterns of disease and results of treatment.

Longo WE, Vernava AM 3rd, Wade TP, Coplin MA, Virgo KS, Johnson FE.

Am Surg. 1995 Jun;61(6):495-500.

PMID:
7762897
12.

Evaluation of alternate messages on an electronic message strip to recruit subjects to a smoking-cessation program.

Johnson FE, Katranides M, Coplin MA, Daly JL, Wade TP, Kraybill WG, Virgo KS.

J Cancer Educ. 1995 Spring;10(1):31-3.

PMID:
7772463
13.

Periampullary cancer treatment in U.S. Department of Veterans Affairs hospitals: 1987-1991.

Wade TP, Coplin MA, Virgo KS, Johnson FE.

Surgery. 1994 Oct;116(4):819-25; discussion 825-6.

PMID:
7940184
14.

Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.

Longo WE, Vernava AM 3rd, Wade TP, Coplin MA, Virgo KS, Johnson FE.

Ann Surg. 1994 Jul;220(1):40-9.

15.

Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American Society of Colon and Rectal Surgeons.

Vernava AM 3rd, Longo WE, Virgo KS, Coplin MA, Wade TP, Johnson FE.

Dis Colon Rectum. 1994 Jun;37(6):573-83.

PMID:
8200237

Supplemental Content

Loading ...
Support Center